Rani Therapeutics Holdings annual net debt
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Net Debt Growth & History (RANI)
Rani Therapeutics Holdings's net debt was −$14.3M for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$14.3M | −$40.2M | — |
| 2024 | 2024-12-31 | $25.9M | $1.7M | +7.06% |
| 2023 | 2023-12-31 | $24.2M | $21.0M | +655.69% |
| 2022 | 2022-12-31 | $3.2M | $120.7M | — |
| 2021 | 2021-12-31 | −$117.5M | −$48.2M | — |
| 2020 | 2020-12-31 | −$69.3M | — | — |
Rani Therapeutics Holdings quarterly net debt
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$1.3M | −$12.7M | — |
| Q1 2026 | 2026-03-31 | −$5.7M | −$21.3M | — |
| Q4 2025 | 2025-12-31 | −$14.3M | −$40.2M | — |
| Q3 2025 | 2025-09-30 | $13.4M | −$16.0M | −54.47% |
| Q2 2025 | 2025-06-30 | $11.4M | −$19.3M | −62.90% |
| Q1 2025 | 2025-03-31 | $15.6M | −$13.0M | −45.47% |
| Q4 2024 | 2024-12-31 | $25.9M | $1.7M | +7.06% |
| Q3 2024 | 2024-09-30 | $29.5M | $4.1M | +16.38% |
| Q2 2024 | 2024-06-30 | $30.7M | $7.8M | +34.17% |
| Q1 2024 | 2024-03-31 | $28.5M | $16.9M | +145.00% |
| Q4 2023 | 2023-12-31 | $24.2M | $21.0M | +655.69% |
| Q3 2023 | 2023-09-30 | $25.3M | $37.1M | — |
| Q2 2023 | 2023-06-30 | $22.9M | $119.1M | — |
| Q1 2023 | 2023-03-31 | $11.6M | $118.3M | — |
| Q4 2022 | 2022-12-31 | $3.2M | $120.7M | — |
| Q3 2022 | 2022-09-30 | −$11.8M | $117.9M | — |
| Q2 2022 | 2022-06-30 | −$96.2M | −$30.8M | — |
| Q1 2022 | 2022-03-31 | −$106.7M | — | — |
| Q4 2021 | 2021-12-31 | −$117.5M | −$48.2M | — |
| Q3 2021 | 2021-09-30 | −$129.7M | — | — |
| Q2 2021 | 2021-06-30 | −$65.4M | — | — |
| Q4 2020 | 2020-12-31 | −$69.3M | — | — |
Rani Therapeutics Holdings net debt trends
Over the last five fiscal years, Rani Therapeutics Holdings's net debt increased from −$69.3M to −$14.3M, a change of $55.0M. The latest reported quarter, Q2 2026, shows −$1.3M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗